CTRI/2024/07/071601尚未招募Unknown
An open labelled single arm study to evaluate the effect of Marma therapy on Shankha marma in Alpa nidrata - NI
Dr Arya P0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patient who comes under the score range of 8-14 in Insomnia Severity Index(Sub Threshold Insomnia).
排除标准
- •Insomnia due to chronic disorders.
- •Those who are on sedatives and tranquilizers.
- •Previous history of injury around selected marma points.
- •Pregnant and lactating women.
研究者
相似试验
尚未招募
3 期
The Effect of Shephalika Patra Kwatha(Medicated decoction) and Gandharva Hastadi(Medicated oil)Taila the Management of Gridhrasi(Sciatica)CTRI/2021/08/035875Dr PALKI BORUAH
已完成
1 期
To evaluate The Effect Of Murvadya Choorna Vati In Pandu Vyadhi (Iron Deficiency Anaemia�)CTRI/2018/02/012256Self60
招募中
1 期
An open label, single arm study to evaluate single and multiple dose pharmacokinetics, safety and tolerability, and to explore clinical outcomes of treatment with intravenous (IV) zanamivir in neonates and infants under 6 months of age with confirmed complicated influenza infection.CTIS2024-510663-34-00Glaxosmithkline Research & Development Limited12
进行中（未招募）
1 期
An open label, single arm study to evaluate the pharmacokinetics, safety and tolerability of intravenous (IV) zanamivir in hospitalised neonates and infants under 6 months of age with confirmed influenza infectioInfluenzaEUCTR2019-001588-63-NLGlaxoSmithKline Research & Development Limited12
进行中（未招募）
1 期
An open label, single arm study to evaluate the pharmacokinetics, safety and tolerability of intravenous (IV) zanamivir in hospitalised neonates and infants under 6 months of age with confirmed influenza infectioInfluenzaEUCTR2019-001588-63-PLGlaxoSmithKline Research & Development Limited12